top of page

Poster 46


Bimekizumab versus secukinumab continuous maintenance of response at every visit through one year in patients with moderate to severe plaque psoriasis: Post-hoc results from the BE RADIANT phase 3b trial

Authors: Richard B. Warren, Curdin Conrad, Peter Foley, Lars Iversen, Richard G. Langley, Georgios Kokolakis, Leah Davis, Veerle Vanvoorden, Susanne Wiegratz, Joseph F. Merola


POSTER 46

< PREVIOUS POSTER NEXT POSTER >

7 views

QUESTIONS, COMMENTS, & SURVEY

Please Rate This PosterPoorFairGoodVery goodExcellentPlease Rate This Poster
Thank you for submitting your feedback!

Search by Poster Number

Topics_Poster_Sq_10.jpg
Topics_Poster_Sq_11.jpg
Topics_Poster_Sq_12.jpg
Topics_Poster_Sq_13.jpg
Topics_Poster_Sq_14.jpg
Topics_Poster_Sq_15.jpg
Topics_Poster_Sq_16.jpg
bottom of page